Radio and PodcastRadio and PodcastLive Radio & Podcasts
Endurance Part 2 artwork
Science & Medicine

Endurance Part 2

OncoPharm by OncoPharmPod

Jul 16, 202600:15:12Science & Medicine

Did lenalidomide maintenance in multiple myeloma just get limited to 2 years? Endurance Trial, Part 2: Learning Oncology Companion:

About This Episode

Endurance Part 2 is an episode from OncoPharm by OncoPharmPod. Did lenalidomide maintenance in multiple myeloma just get limited to 2 years? Endurance Trial, Part 2: Learning Oncology Companion: The episode was published on Jul 16, 2026 and...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 16, 2026, 00:15:12 long, audio available.

Related Episodes

Continue listening to more episodes from OncoPharm.

Iberdomide

Aug 20, 2026 - 00:15:37

CELMoDs are here, but are they here to stay? CELMoD/IMiD review article: Download the Oncology Learning C...

Zidesamtinib & PPIs in Pacific

Jul 30, 2026 - 00:16:32

A new drug is approved for ROS1 NSCLC after a prior TKI (with some data in patients after 2 TKIs). Zidesa...

Gedatolisib et al

Jul 23, 2026 - 00:18:16

This week's pod covers some brief updates comparing the timelines of the FDA approvals for daraxonrasib v...